NICE gets ready to assess new dementia treatments.

NICE’s methods and processes for evaluating new treatments for use in the NHS are appropriate for the new class of Alzheimer’s drugs but key issues need to be considered, a new report has found.

Read news story


NICE Talks podcasts

NICE Talks brings you the real life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 07973 970 534 |